Video completo de la Primera Edición de REPRIMARIA de 8 del Mayo 2024
The efficacy and safety of mepolizumab in patients with COPD has been investigated in two placebo-controlled Phase 3 trials, METREX and METREO, and theongoing MATINEE trial.
Durante la jornada RESPrimaria se destacó la importancia de la prevención y el diagnóstico precoz en la lucha contra estas patologías.
Más de 900 sanitarios se reunirán de forma presencial y online, este miércoles en Barcelona, para mejorar la prevención y el tratamiento de las
patologías respiratorias.
Treatment with LABA/LAMA is recommended in GOLD B patients. We hypothesized that triple therapy (LABA/LAMA/ICS) will be superior to LABA/LAMA in achieving and maintaining clinical control
The latest episode of Coffee Talk sees co-chairs of the ERS Clinical Research Collaboration CADSET, Prof. Erik Melén and Prof. Rosa Faner, catch up to discuss the topic of the new lung function tracker tool.
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous condition. We hypothesized that the unbiased integration of different COPD lung omics using a novel multi-layer approach may unravel mechanisms associated with clinical characteristics.
COPD results from gene-environment interactions over the lifetime. These interactions are captured by epigenetic changes
COPD is the elephant in the room for many patients with CVDs.
